Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ambuj Kumar
Benjamin Djulbegovic

Showing results (11-20 of 635) with videos related to

Pageof 64
Sort By:
Cancer Control : Journal of the Moffitt Cancer Center|February 25, 2003
Nonmyeloablative allogeneic stem-cell transplantation for hematologic malignancies: a systematic reviewBenjamin Djulbegovic, Jerome Seidenfeld, Claudia Bonnell, et al.
American Journal of Hematology|December 2, 2010
Thalidomide versus bortezomib based regimens as first-line therapy for patients with multiple myeloma: a systematic reviewAmbuj Kumar, Iztok Hozo, Keath Wheatley, et al.
Plos One|August 6, 2015
Dual Processing Model for Medical Decision-Making: An Extension to Diagnostic TestingAthanasios Tsalatsanis, Iztok Hozo, Ambuj Kumar, et al.
BMC Medical Research Methodology|April 23, 2011
Instrumental variable meta-analysis of individual patient data: application to adjust for treatment non-complianceBranko Miladinovic, Ambuj Kumar, Iztok Hozo, et al.
BMJ Open|October 23, 2014
Benchmarks for detecting 'breakthroughs' in clinical trials: empirical assessment of the probability of large treatment effects using kernel density estimationBranko Miladinovic, Ambuj Kumar, Rahul Mhaskar, et al.
BMJ Open|January 8, 2017
Treatment targeted at underlying disease versus palliative care in terminally ill patients: a systematic reviewTea Reljic, Ambuj Kumar, Farina A Klocksieben, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2007
Treatment tolerance and efficacy in geriatric oncology: a systematic review of phase III randomized trials conducted by five National Cancer Institute-sponsored cooperative groupsAmbuj Kumar, Heloisa P Soares, Lodovico Balducci, et al.
Systematic Reviews|February 6, 2013
Survival of patients with non-small cell lung cancer without treatment: a systematic review and meta-analysisHesborn Wao, Rahul Mhaskar, Ambuj Kumar, et al.
Contemporary Clinical Trials|January 1, 2013
Trial sequential analysis may be insufficient to draw firm conclusions regarding statistically significant treatment differences using observed intervention effects: a case study of meta-analyses of multiple myeloma trialsBranko Miladinovic, Ambuj Kumar, Iztok Hozo, et al.
Journal of the National Cancer Institute|January 15, 2009
Tandem versus single autologous hematopoietic cell transplantation for the treatment of multiple myeloma: a systematic review and meta-analysisAmbuj Kumar, Mohamed A Kharfan-Dabaja, Axel Glasmacher, et al.
Pageof 64

Showing results (11-20 of 635) with videos related to

Sort By:
Pageof 64
Cancer Control : Journal of the Moffitt Cancer Center|February 25, 2003
Nonmyeloablative allogeneic stem-cell transplantation for hematologic malignancies: a systematic reviewBenjamin Djulbegovic, Jerome Seidenfeld, Claudia Bonnell, et al.
American Journal of Hematology|December 2, 2010
Thalidomide versus bortezomib based regimens as first-line therapy for patients with multiple myeloma: a systematic reviewAmbuj Kumar, Iztok Hozo, Keath Wheatley, et al.
Plos One|August 6, 2015
Dual Processing Model for Medical Decision-Making: An Extension to Diagnostic TestingAthanasios Tsalatsanis, Iztok Hozo, Ambuj Kumar, et al.
BMC Medical Research Methodology|April 23, 2011
Instrumental variable meta-analysis of individual patient data: application to adjust for treatment non-complianceBranko Miladinovic, Ambuj Kumar, Iztok Hozo, et al.
BMJ Open|October 23, 2014
Benchmarks for detecting 'breakthroughs' in clinical trials: empirical assessment of the probability of large treatment effects using kernel density estimationBranko Miladinovic, Ambuj Kumar, Rahul Mhaskar, et al.
BMJ Open|January 8, 2017
Treatment targeted at underlying disease versus palliative care in terminally ill patients: a systematic reviewTea Reljic, Ambuj Kumar, Farina A Klocksieben, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2007
Treatment tolerance and efficacy in geriatric oncology: a systematic review of phase III randomized trials conducted by five National Cancer Institute-sponsored cooperative groupsAmbuj Kumar, Heloisa P Soares, Lodovico Balducci, et al.
Systematic Reviews|February 6, 2013
Survival of patients with non-small cell lung cancer without treatment: a systematic review and meta-analysisHesborn Wao, Rahul Mhaskar, Ambuj Kumar, et al.
Contemporary Clinical Trials|January 1, 2013
Trial sequential analysis may be insufficient to draw firm conclusions regarding statistically significant treatment differences using observed intervention effects: a case study of meta-analyses of multiple myeloma trialsBranko Miladinovic, Ambuj Kumar, Iztok Hozo, et al.
Journal of the National Cancer Institute|January 15, 2009
Tandem versus single autologous hematopoietic cell transplantation for the treatment of multiple myeloma: a systematic review and meta-analysisAmbuj Kumar, Mohamed A Kharfan-Dabaja, Axel Glasmacher, et al.
Pageof 64